why not use dpp4 and glp 1 together Clinical of DPP-4 Inhibitors DPP-4 Inhibitors (Gliptins): Mechanism, Pharmacokinetics,

Consequently, HMP activity is suppressed, leading to decreased ability to generate NADPH and maintain glutathione in the reduced state

These results suggest that L-carnitine and betaine enhance fatty acid oxidation and inhibit fat deposition by suppressing MPO gene expression, further supporting the reliability of the multi-omics data

Clinical studies The effects of treatment with rhGH on renal recovery in patients with AKI was investigated in two RCTs

This Review highlights the mechanisms targeted by GLP-1-based therapies, and emphasizes current developments in incretin research that are relevant to cardiovascular risk and disease, as well as treatment with GLP-1 receptor agonists